Sight Sciences (SGHT) Operating Leases (2023 - 2026)

Sight Sciences' (SGHT) quarterly Operating Leases came in at $870000.0 in Q1 2026, up 165.24% year-on-year from $328000.0 in Q1 2025, and up 1751.06% quarter-over-quarter from $47000.0 in Q3 2025.

Sight Sciences (SGHT) Operating Leases (2023 - 2026) Analysis & Trends

Sight Sciences' Operating Leases history runs 4 years deep, the most recent figure standing at $870000.0 for Q1 2026.

  • On a quarterly basis, Operating Leases rose 165.24% year-over-year to $870000.0 in Q1 2026; TTM through Mar 2026 was $870000.0, a 165.24% increase from a year earlier, with the FY2024 full-year figure at $473000.0, down 48.25% from the prior year.
  • Operating Leases improved to $870000.0 in Q1 2026 per SGHT's latest filing, from $47000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $914000.0 in Q4 2023 and bottomed at $47000.0 in Q3 2025.
  • The 4-year median for Operating Leases is $543500.0 (2024), against an average of $522000.0.
  • Across the five-year window, Operating Leases slumped 92.35% in 2025 and soared 165.24% in 2026, its largest moves.
  • Year by year, Operating Leases stood at $914000.0 in 2023, then slumped by 48.25% to $473000.0 in 2024, then sank by 90.06% to $47000.0 in 2025, then soared by 1751.06% to $870000.0 in 2026.
  • Per Business Quant, the three latest SGHT Operating Leases figures stand at $870000.0 (Q1 2026), $47000.0 (Q3 2025), and $183000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Sight Sciences 253.53 Mn 168.57 Mn 16.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 870,000.00
Sep 30, 2025 47,000.00
Jun 30, 2025 183,000.00
Mar 31, 2025 328,000.00
Dec 31, 2024 473,000.00
Sep 30, 2024 614,000.00
Jun 30, 2024 747,000.00
Dec 31, 2023 914,000.00